FUNDAMENTALS |
MarketCap: |
4.59 mill
|
EPS: |
-0.260
|
P/E: |
-0.100
|
Earnings Date: |
Oct 29, 2023 |
SharesOutstanding: |
183.40 mill
|
Avg Daily Volume: |
0 mill
|
RATINGS |
Rating CashFlow: |
Strong Buy
|
|
Return On Equity: |
Strong Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Strong Buy
|
|
P/E: |
Sell
|
|
Price To Book: |
Strong Buy
|
|
QUARTER GROWTHS |
|
4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.100 | sector: PE -3.05
|
PE RATIO: COMPANY / INDUSTRY |
0.00x
|
Company: PE -0.100 | industry: PE 222.16
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ -0.0530 - 0.0810
( +/- 478.57%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2023-07-15 | Shah Sanket | Buy | 350 000 | Common Stock |
2023-07-21 | Shah Sanket | Sell | 30 364 | Common Stock |
2023-07-15 | Podbelski Adam Andrew | Buy | 350 000 | Common Stock |
2023-07-17 | Podbelski Adam Andrew | Sell | 89 901 | Common Stock |
2023-07-15 | Shah Sanket | Sell | 0 | Common Stock |
INSIDER POWER |
-58.52
|
Last
87 transactions |
Buy:
4 410 866 | Sell:
16 363 019 |
Forecast:
01:40 - $-0.618
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.0250 (0.00% )
|
Volume |
96.17 mill
|
Avg. Vol. |
0 mill
|
% of Avg. Vol |
0 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For VRAY
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Last 10 Buy Signals
Date |
Signal |
@ |
BTGUSD | Apr 26 - 15:33 | $34.25 |
APLS | Apr 26 - 15:33 | $50.17 |
AGNC | Apr 26 - 15:33 | $9.34 |
BSY | Apr 26 - 15:32 | $54.18 |
CLSK | Apr 26 - 15:32 | $19.03 |
WWD | Apr 26 - 15:31 | $150.65 |
SNPS | Apr 26 - 15:31 | $545.42 |
AAVEUSD | Apr 26 - 15:31 | $90.59 |
EVRG | Apr 26 - 15:30 | $51.95 |
MGCUSD | Apr 26 - 15:21 | 2 348.90 |